Immune Checkpoint Inhibitors Market Report – Research, Industry Analysis Reports and Market Demands

Global Immune Checkpoint Inhibitors Market Analysis 2013-2018 and Forecast 2019-2024

Request for Sample of this report

Buy now

Table of Content

1 Industry Overview

1.1 Immune Checkpoint Inhibitors Industry
- 1.1.1 Overview
- 1.1.2 Development of Immune Checkpoint Inhibitors
1.2 Market Segment
- 1.2.1 Upstream
- 1.2.2 Downstream
1.3 Cost Analysis

2 Industry Environment (PEST Analysis)

2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology

3 Immune Checkpoint Inhibitors Market by Type

3.1 By Type
- 3.1.1 PD-1/PD-L1
- 3.1.2 CTLA-4
3.2 Market Size
3.3 Market Forecast

4 Major Companies List

4.Immune Checkpoint Inhibitors Bristol Myer Squibb (Company Profile, Sales Data etc.)

4.2 AstraZeneca (Company Profile, Sales Data etc.)
4.3 Merck & Co. (Company Profile, Sales Data etc.)
4.4 Roche / Genentech (Company Profile, Sales Data etc.)
4.5 Incyte Corporation (Company Profile, Sales Data etc.)
4.6 NewLink Genetics (Company Profile, Sales Data etc.)
4.7 ArGEN-X (Company Profile, Sales Data etc.)
4.8 Seattle Genetics (Company Profile, Sales Data etc.)
4.9 Pfizer (Company Profile, Sales Data etc.)
4.10 MacroGenics (Company Profile, Sales Data etc.)
4.11 Celldex Therapeutics (Company Profile, Sales Data etc.)
4.12 CureTech (Company Profile, Sales Data etc.)
4.13 Immutep (Company Profile, Sales Data etc.)
4.14 Innate Pharma (Company Profile, Sales Data etc.)
4.15 Sorrento Therapeutics (Company Profile, Sales Data etc.)
4.16 GlaxoSmithKline (Company Profile, Sales Data etc.)
4.17 GITR, Inc (Company Profile, Sales Data etc.)

5 Market Competition

5.1 Company Competition
5.2 Regional Market by Company

6 Demand by End Market

6.1 Demand Situation
- 6.1.1 Demand in Lung Cancer
- 6.1.2 Demand in Colorectal Cancer
- 6.1.3 Demand in Breast Cancer
- 6.1.4 Demand in Prostate Cancer
- 6.1.5 Demand in Melanoma
- 6.1.6 Demand in Blood Cancer
- 6.1.7 Demand in Others
6.2 Regional Demand Comparison
6.3 Demand Forecast

7 Region Operation

7.1 Regional Production
7.2 Regional Market
7.3 by Region
- 7.3.1 North America
  - 7.3.1.1 Overview
  - 7.3.1.2 by Country (U.S., Canada, Mexico)
- 7.3.2 Europe
  - 7.3.2.1 Overview
  - 7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
- 7.3.3 Asia-Pacific
  - 7.3.3.1 Overview
  - 7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
- 7.3.4 South America
  - 7.3.4.1 Overview
  - 7.3.4.2 by Country (Brazil, Argentina etc.)
- 7.3.5 Middle East & Africa
  - 7.3.5.1 Overview
  - 7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
7.4 Regional Import & Export
7.5 Regional Forecast

8 Marketing & Price

8.1 Price and Margin
- 8.1.1 Price Trends
- 8.1.2 Factors of Price Change
- 8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel

9 Research Conclusion

List of Tables

Table Upstream Segment of Immune Checkpoint Inhibitors

Table Application Segment of Immune Checkpoint Inhibitors

Table Global Immune Checkpoint Inhibitors Market 2013-2024, by Application, in USD Million

Table Major Company List of PD-1/PD-L1

Table Major Company List of CTLA-4

Table Global Immune Checkpoint Inhibitors Market 2013-2018, by Type, in USD Million

Table Global Immune Checkpoint Inhibitors Market 2013-2018, by Type, in Volume

Table Global Immune Checkpoint Inhibitors Market Forecast 2019-2024, by Type, in USD Million

Table Global Immune Checkpoint Inhibitors Market Forecast 2019-2024, by Type, in Volume

Table Bristol Myer Squibb Overview List

Table Immune Checkpoint Inhibitors Business Operation of Bristol Myer Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table AstraZeneca Overview List

Table Immune Checkpoint Inhibitors Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Merck & Co. Overview List

Table Immune Checkpoint Inhibitors Business Operation of Merck & Co. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Roche / Genentech Overview List

Table Immune Checkpoint Inhibitors Business Operation of Roche / Genentech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Incyte Corporation Overview List

Table Immune Checkpoint Inhibitors Business Operation of Incyte Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table NewLink Genetics Overview List

Table Immune Checkpoint Inhibitors Business Operation of NewLink Genetics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table ArGEN-X Overview List

Table Immune Checkpoint Inhibitors Business Operation of ArGEN-X (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Seattle Genetics Overview List

Table Immune Checkpoint Inhibitors Business Operation of Seattle Genetics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Pfizer Overview List

Table Immune Checkpoint Inhibitors Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table MacroGenics Overview List

Table Immune Checkpoint Inhibitors Business Operation of MacroGenics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Celldex Therapeutics Overview List

Table Immune Checkpoint Inhibitors Business Operation of Celldex Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table CureTech Overview List

Table Immune Checkpoint Inhibitors Business Operation of CureTech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Immutep Overview List

Table Immune Checkpoint Inhibitors Business Operation of Immutep (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Innate Pharma Overview List

Table Immune Checkpoint Inhibitors Business Operation of Innate Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Sorrento Therapeutics Overview List

Table Immune Checkpoint Inhibitors Business Operation of Sorrento Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table GlaxoSmithKline Overview List

Table Immune Checkpoint Inhibitors Business Operation of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table GITR, Inc Overview List

Table Immune Checkpoint Inhibitors Business Operation of GITR, Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Global Immune Checkpoint Inhibitors Sales Revenue 2013-2018, by Company, in USD Million

Table Global Immune Checkpoint Inhibitors Sales Revenue Share, by Company, in USD Million

Table Global Immune Checkpoint Inhibitors Sales Volume 2013-2018, by Company, in Volume

Table Global Immune Checkpoint Inhibitors Sales Volume Share 2013-2018, by Company, in Volume

Table Major Consumers List and Overview

Table Regional Demand Comparison List

Table Major Application in Different Regions

Table Immune Checkpoint Inhibitors Demand Forecast 2019-2024, by Application, in USD Million

Table Immune Checkpoint Inhibitors Demand Forecast 2019-2024, by Application, in Volume

Table Immune Checkpoint Inhibitors Production 2013-2018, by Region, in USD Million

Table Immune Checkpoint Inhibitors Production 2013-2018, by Region, in Volume

Table Global Immune Checkpoint Inhibitors Market 2013-2018, by Region, in USD Million

Table Global Immune Checkpoint Inhibitors Market Share 2013-2018, by Region, in USD Million

Table Global Immune Checkpoint Inhibitors Market 2013-2018, by Region, in Volume

Table Global Immune Checkpoint Inhibitors Market Share 2013-2018, by Region, in Volume

Table North America Immune Checkpoint Inhibitors Market Size 2013-2018, by Country, in USD Million

Table North America Immune Checkpoint Inhibitors Market Size 2013-2018, by Country, in Volume

Table Europe Immune Checkpoint Inhibitors Market Size 2013-2018, by Country, in USD Million

Table Europe Immune Checkpoint Inhibitors Market Size 2013-2018, by Country, in Volume

Table Asia-Pacific Immune Checkpoint Inhibitors Market Size 2013-2018, by Country, in USD Million

Table Asia-Pacific Immune Checkpoint Inhibitors Market Size 2013-2018, by Country, in Volume

Table South America Immune Checkpoint Inhibitors Market Size 2013-2018, by Country, in USD Million

Table South America Immune Checkpoint Inhibitors Market Size 2013-2018, by Country, in Volume

Table Middle East & Africa Immune Checkpoint Inhibitors Market Size 2013-2018, by Country, in USD Million

Table Middle East & Africa Immune Checkpoint Inhibitors Market Size 2013-2018, by Country, in Volume

Table Immune Checkpoint Inhibitors Market Forecast 2019-2024, by Region, in USD Million

Table Immune Checkpoint Inhibitors Market Forecast 2019-2024, by Region, in Volume

Table Price Factors List

List of Figures

Figure Global Immune Checkpoint Inhibitors Market Growth 2013-2018, by Type, in USD Million

Figure Global Immune Checkpoint Inhibitors Market Growth 2013-2018, by Type, in Volume

Figure North America Immune Checkpoint Inhibitors Market Concentration, in 2018

Figure Europe Immune Checkpoint Inhibitors Market Market Concentration, in 2018

Figure Asia-Pacific Immune Checkpoint Inhibitors MMarket Concentration, in 2018

Figure South America Immune Checkpoint Inhibitors Market Concentration, in 2018

Figure Middle East & Africa Immune Checkpoint Inhibitors Market Concentration, in 2018

Figure Immune Checkpoint Inhibitors Demand in Lung Cancer, 2013-2018, in USD Million

Figure Immune Checkpoint Inhibitors Demand in Lung Cancer, 2013-2018, in Volume

Figure Immune Checkpoint Inhibitors Demand in Colorectal Cancer, 2013-2018, in USD Million

Figure Immune Checkpoint Inhibitors Demand in Colorectal Cancer, 2013-2018, in Volume

Figure Immune Checkpoint Inhibitors Demand in Breast Cancer, 2013-2018, in USD Million

Figure Immune Checkpoint Inhibitors Demand in Breast Cancer, 2013-2018, in Volume

Figure Immune Checkpoint Inhibitors Demand in Prostate Cancer, 2013-2018, in USD Million

Figure Immune Checkpoint Inhibitors Demand in Prostate Cancer, 2013-2018, in Volume

Figure Immune Checkpoint Inhibitors Demand in Melanoma, 2013-2018, in USD Million

Figure Immune Checkpoint Inhibitors Demand in Melanoma, 2013-2018, in Volume

Figure Immune Checkpoint Inhibitors Demand in Blood Cancer, 2013-2018, in USD Million

Figure Immune Checkpoint Inhibitors Demand in Blood Cancer, 2013-2018, in Volume

Figure Immune Checkpoint Inhibitors Demand in Others, 2013-2018, in USD Million

Figure Immune Checkpoint Inhibitors Demand in Others, 2013-2018, in Volume

Figure North America Immune Checkpoint Inhibitors Market Size and Growth 2013-2018, in USD Million

Figure North America Immune Checkpoint Inhibitors Market Size and Growth 2013-2018, in Volume

Figure Europe Immune Checkpoint Inhibitors Market Size and Growth 2013-2018, in USD Million

Figure Europe Immune Checkpoint Inhibitors Market Size and Growth 2013-2018, in Volume

Figure Asia-Pacific Immune Checkpoint Inhibitors Market Size and Growth 2013-2018, in USD Million

Figure Asia-Pacific Immune Checkpoint Inhibitors Market Size and Growth 2013-2018, in Volume

Figure South America Immune Checkpoint Inhibitors Market Size and Growth 2013-2018, in USD Million

Figure South America Immune Checkpoint Inhibitors Market Size and Growth 2013-2018, in Volume

Figure Middle East & Africa Immune Checkpoint Inhibitors Market Size and Growth 2013-2018, in USD Million

Figure Middle East & Africa Immune Checkpoint Inhibitors Market Size and Growth 2013-2018, in Volume

Figure Marketing Channels Overview

Description

Snapshot
The global Immune Checkpoint Inhibitors market will reach xxx Million USD in 2019 and CAGR xx% 2019-2024. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Immune Checkpoint Inhibitors by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
PD-1/PD-L1
CTLA-4
Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):
Bristol Myer Squibb
AstraZeneca
Merck & Co.
Roche / Genentech
Incyte Corporation
NewLink Genetics
ArGEN-X
Seattle Genetics
Pfizer
MacroGenics
Celldex Therapeutics
CureTech
Immutep
Innate Pharma
Sorrento Therapeutics
GlaxoSmithKline
GITR, Inc
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Lung Cancer
Colorectal Cancer
Breast Cancer
Prostate Cancer
Melanoma
Blood Cancer
Others
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)